NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 1711225 | Fosgonimeton (ATH-1017) | 2093305-05-4 | ≧98.0% | _2093305-05-4.png) |
| Fosgonimeton (ATH-1017) is a small molecule which enhance the activity of hepatocyte | ||||
| 16122939 | Emeramide ( BDTH2 ) | 351994-94-0 | ≧98.0% |  |
| Emeramide, also known as BDTH2, is a mercury and heavy metal chelator. BDTH2 molecule | ||||
| 171454 | 1-(4-Bromo-6- methylpyridin-2- yl)ethan-1-one | 1060810-24-3 | ≧98.0% | ethan-1-one_1060810-24-3.png) |
| 1-(4-Bromo-6- methylpyridin-2- yl)ethan-1-one, CAS 1060810-24-3. | ||||
| 21254 | 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-INDOLE | 690632-17-8 | 98% Min. | -1-(TRIISOPROPYLSILYL)-1H-INDOLE_690632-17-8.png) |
| 171653 | 4-Bromo-6-methylpyridine-2-carbonitrile | 886372-53-8 | ≧95.0% |  |
| 4-Bromo-6-methylpyridine-2-carbonitrile, CAS 886372-53-8 | ||||
| 20103004 | 2,6-difluoro-3,5-dimethoxybenzeneamine | 651734-54-2 | ≧98.0% |  |
| 2,6-difluoro-3,5-dimethoxybenzeneamine is a key intermeidate ofPemigatinib.1Kg~10Kg s | ||||
| 21075 | 1-cyanocyclohexyl 4-methylbenzenesulfonate | 90775-01-2 | ≧98.0% |  |
| 1-cyanocyclohexyl 4-methylbenzenesulfonate (CAS 90775-01-2 ) is an important building | ||||
| 2091204 | 5-hydroxy-2,4-dimethylpyrimidine | 412003-95-3 | ≧96.0% | _412003-95-3.png) |
| 2,4-dimethylpyrimidin-5-ol is a key intermidiate ofLemborexant. Kg scale may be provi | ||||
| 231106 | PDS-0330 | 2904682-19-3 | ≧98.0% |  |
| PDS0330 is a new claudin-1 inhibitor in Colorectal Cancer. | ||||
| 20645 | CP-506 ( Synonyms: SN-36506 ) | 2227304-19-8 | 98% Min. |  |
| CP-506 (SN-36506) is an hypoxia-activated prodrug of a DNA-alkylating nitrogen mustar | ||||
| 191123 | Tafenoquine succinate | 106635-81-8 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| 20646 | TNG908 | 2760481-53-4 | ≧98.0% |  |
| TNG908 is a clinical stage MTA-cooperative PRMT5 inhibitor that is selectively active | ||||